![](/img/cover-not-exists.png)
Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes
Nyström, Thomas, Bodegard, Johan, Nathanson, David, Thuresson, Marcus, Norhammar, Anna, Eriksson, Jan W.Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.12889
Date:
March, 2017
File:
PDF, 1.36 MB
english, 2017